• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国内脏脂肪素指数与良性前列腺增生风险之间的关联:一项全国性前瞻性队列研究。

Association between the Chinese Visceral Adiposity Index and the risk of Benign Prostatic Hyperplasia: a national prospective cohort study.

作者信息

Li Bing, Li Junping, Sun Chao, Sun Yaodong, Zhang Zhiqiang

机构信息

Department of Urology, Tianjin Medical University General Hospital, Tianjin, China.

Department of Oncology, Zibo City Municipal Hospital, Zibo, China.

出版信息

Sci Rep. 2025 Jan 2;15(1):222. doi: 10.1038/s41598-024-83960-w.

DOI:10.1038/s41598-024-83960-w
PMID:39747472
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11695709/
Abstract

To investigate the relationship between the Chinese Visceral Adiposity Index (CVAI) and the risk of developing Benign Prostatic Hyperplasia (BPH). Using data from the China Health and Retirement Longitudinal Study (CHARLS), we included 3,295 men aged 45 years and older. Multivariate logistic regression and restricted cubic spline models were employed to analyze the association between CVAI and the risk of BPH. During the 4-year follow-up period, 267 cases of BPH were identified. CVAI was positively associated with the risk of developing BPH (OR = 1.23, 95% CI: 1.07-1.42), with a significant dose-response relationship (P < 0.001). Stratified analysis showed that the effect of CVAI on BPH risk was consistent across various subgroups. There is a positive correlation between CVAI and the risk of developing BPH. Managing visceral fat content and maintaining a healthy fat distribution pattern may help reduce the risk of BPH.

摘要

为研究中国内脏脂肪指数(CVAI)与良性前列腺增生(BPH)发病风险之间的关系。利用中国健康与养老追踪调查(CHARLS)的数据,我们纳入了3295名45岁及以上的男性。采用多因素逻辑回归和受限立方样条模型分析CVAI与BPH发病风险之间的关联。在4年的随访期内,共确诊267例BPH病例。CVAI与BPH发病风险呈正相关(OR = 1.23,95%CI:1.07 - 1.42),具有显著的剂量反应关系(P < 0.001)。分层分析表明,CVAI对BPH风险的影响在各个亚组中是一致的。CVAI与BPH发病风险之间存在正相关。控制内脏脂肪含量并维持健康的脂肪分布模式可能有助于降低BPH的风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab87/11695709/7060447f2a0c/41598_2024_83960_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab87/11695709/b09b56d32b2e/41598_2024_83960_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab87/11695709/919a7d048772/41598_2024_83960_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab87/11695709/7060447f2a0c/41598_2024_83960_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab87/11695709/b09b56d32b2e/41598_2024_83960_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab87/11695709/919a7d048772/41598_2024_83960_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab87/11695709/7060447f2a0c/41598_2024_83960_Fig3_HTML.jpg

相似文献

1
Association between the Chinese Visceral Adiposity Index and the risk of Benign Prostatic Hyperplasia: a national prospective cohort study.中国内脏脂肪素指数与良性前列腺增生风险之间的关联:一项全国性前瞻性队列研究。
Sci Rep. 2025 Jan 2;15(1):222. doi: 10.1038/s41598-024-83960-w.
2
Association between Chinese visceral adiposity index and lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH): a national cohort study.中国内脏脂肪指数与提示良性前列腺增生的下尿路症状(LUTS/BPH)之间的关联:一项全国性队列研究。
BMC Urol. 2025 Jan 23;25(1):15. doi: 10.1186/s12894-025-01698-7.
3
Dose-response association between Chinese visceral adiposity index and cardiovascular disease: a national prospective cohort study.中国内脏脂肪指数与心血管疾病之间的剂量反应关联:一项全国性前瞻性队列研究。
Front Endocrinol (Lausanne). 2024 Apr 18;15:1284144. doi: 10.3389/fendo.2024.1284144. eCollection 2024.
4
Impact of Chinese visceral adiposity index on all-cause mortality risk in community-dwelling older adults: a prospective cohort study.中国内脏脂肪指数对社区居住老年人全因死亡风险的影响:一项前瞻性队列研究
Aging Clin Exp Res. 2024 Dec 3;36(1):230. doi: 10.1007/s40520-024-02891-8.
5
Chinese Visceral Adiposity Index Predict Prehypertension Progression and Regression: A Prospective Cohort Study Involving Middle-Aged and Older Adults.中国内脏脂肪指数预测高血压前期进展和缓解:一项涉及中老年人的前瞻性队列研究。
Am J Hypertens. 2024 Jul 15;37(8):588-596. doi: 10.1093/ajh/hpae041.
6
Association between Chinese visceral adiposity index and risk of new-onset hypertension in middle-aged and older adults with prediabetes: evidence from a large national cohort study.中国内脏脂肪指数与中年及老年糖尿病前期人群新发高血压风险的关联:一项大型全国队列研究的证据
Front Public Health. 2025 Feb 12;13:1509898. doi: 10.3389/fpubh.2025.1509898. eCollection 2025.
7
Chinese visceral adiposity index and its transition patterns: impact on cardiovascular and cerebrovascular diseases in a national cohort study.中国内脏脂肪指数及其变化模式:对全国队列研究中心血管和脑血管疾病的影响。
Lipids Health Dis. 2024 Apr 29;23(1):124. doi: 10.1186/s12944-024-02105-0.
8
Association between Chinese visceral adiposity index and risk of stroke incidence in middle-aged and elderly Chinese population: evidence from a large national cohort study.中国内脏脂肪指数与中老年中国人卒中发病风险的关联:来自一项大型全国队列研究的证据。
J Transl Med. 2023 Jul 31;21(1):518. doi: 10.1186/s12967-023-04309-x.
9
Dose-response relationship between Chinese visceral adiposity index and type 2 diabetes mellitus among middle-aged and elderly Chinese.中国中老年人群中内脏脂肪指数与 2 型糖尿病的剂量反应关系。
Front Endocrinol (Lausanne). 2022 Oct 5;13:959860. doi: 10.3389/fendo.2022.959860. eCollection 2022.
10
Linear associations of Chinese visceral adiposity index and its change with hyperuricemia: A prospective cohort study.线性关联的中国内脏脂肪指数及其变化与高尿酸血症:前瞻性队列研究。
Nutr Metab Cardiovasc Dis. 2024 Nov;34(11):2472-2479. doi: 10.1016/j.numecd.2024.06.021. Epub 2024 Jul 4.

本文引用的文献

1
Plasma metabolites as mediators in the relationship between inflammation-related proteins and benign prostatic hyperplasia: insights from mendelian randomization.血浆代谢物作为炎症相关蛋白与良性前列腺增生关系的中介物:来自孟德尔随机化的见解。
Sci Rep. 2024 Oct 30;14(1):26152. doi: 10.1038/s41598-024-77515-2.
2
Surgical Complications in the Management of Benign Prostatic Hyperplasia Treatment.良性前列腺增生治疗中手术并发症的处理。
Curr Urol Rep. 2022 May;23(5):83-92. doi: 10.1007/s11934-022-01091-z. Epub 2022 Mar 9.
3
Global, Regional, and National Incidence and Year Lived with Disability for Benign Prostatic Hyperplasia from 1990 to 2019.
全球、区域和国家良性前列腺增生发病率和 1990 年至 2019 年残疾年数。
Am J Mens Health. 2021 Jul-Aug;15(4):15579883211036786. doi: 10.1177/15579883211036786.
4
Benign prostatic hyperplasia - what do we know?良性前列腺增生症——我们了解多少?
BJU Int. 2021 Apr;127(4):389-399. doi: 10.1111/bju.15229. Epub 2020 Sep 24.
5
The New American Urological Association Benign Prostatic Hyperplasia Clinical Guidelines: 2019 Update.《新美国泌尿外科学会良性前列腺增生临床指南:2019 年更新》。
Curr Urol Rep. 2020 Jul 1;21(9):32. doi: 10.1007/s11934-020-00985-0.
6
Effects of inflammatory responses, apoptosis, and STAT3/NF-κB- and Nrf2-mediated oxidative stress on benign prostatic hyperplasia induced by a high-fat diet.炎症反应、细胞凋亡以及STAT3/NF-κB和Nrf2介导的氧化应激对高脂饮食诱导的良性前列腺增生的影响。
Aging (Albany NY). 2019 Aug 14;11(15):5570-5578. doi: 10.18632/aging.102138.
7
Epidemiology of clinical benign prostatic hyperplasia.临床良性前列腺增生症的流行病学
Asian J Urol. 2017 Jul;4(3):148-151. doi: 10.1016/j.ajur.2017.06.004. Epub 2017 Jun 9.
8
A indicator of visceral adipose dysfunction to evaluate metabolic health in adult Chinese.评估成年中国人代谢健康的内脏脂肪功能障碍指标。
Sci Rep. 2016 Dec 1;6:38214. doi: 10.1038/srep38214.
9
Inflammatory mediators in the development and progression of benign prostatic hyperplasia.在良性前列腺增生的发生和发展中的炎症介质。
Nat Rev Urol. 2016 Sep 30;13(10):613-26. doi: 10.1038/nrurol.2016.168.
10
Male Lower Urinary Tract Symptoms and Cardiovascular Events: A Systematic Review and Meta-analysis.男性下尿路症状与心血管事件:系统评价和荟萃分析。
Eur Urol. 2016 Nov;70(5):788-796. doi: 10.1016/j.eururo.2016.07.007. Epub 2016 Jul 20.